Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system
about
Evaluation of protective effects of trehalose on desiccation of epithelial cells in three dimensional reconstructed human corneal epithelium.Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit.Development of a curved, stratified, in vitro model to assess ocular biocompatibility.Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma[Possibilities and limitations of eye drops for glaucoma therapy].Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes.Ocular toxicity of benzalkonium chloride homologs compared with their mixtures.Ocular surface cytotoxicity and safety evaluation of tafluprost, a recently developed anti-glaucoma prostaglandin analog.Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension.Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma.Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK).Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice.Evaluation of Eye Irritation Potential of Solid Substance with New 3D Reconstructed Human Cornea Model, MCTT HCE(TM).Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?Identification of cornifelin and early growth response-1 gene as novel biomarkers for in vitro eye irritation using a 3D reconstructed human cornea model MCTT HCE™.In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.Acute corneal toxicity of latanoprost with different preservatives.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.Estimation of the in vitro eye irritating and inflammatory potential of lipopolysaccharide (LPS) and dust by using reconstituted human corneal epithelium tissue cultures.
P2860
Q34316383-3522DD51-2E22-4BB5-AF81-28DA938226EFQ34708156-40D1BD96-36D0-476A-ABB7-8A49B3E25AEAQ34730252-201FF385-503F-4524-87B4-9566C9E36A8EQ35121491-3E7927F8-965A-496B-A4A7-CB30E050721EQ35170366-8ACD1E18-AB72-4CFF-96BB-5A2BD8E95217Q35444198-BC761C49-5842-4DCA-842C-6C65BEF2869DQ36125697-81115606-1A74-4827-81B2-70046A836CD5Q36385076-33E26051-08B7-4CAD-A3DC-0E31ACD249A0Q36985297-F8EFC14D-D3FF-4C19-A090-2653779F1D4CQ37079208-8B277182-53C6-47B2-9EC6-3937BE7AF2A1Q37579359-E85854D6-CAFD-41D2-860E-998E42FA923DQ38190054-E4EC96F1-BA54-43E3-ADBB-63D296FDD794Q38217464-11BC62E2-DE2B-4318-B1CF-4A9524A1D2C0Q38339962-83552E2B-315B-40B6-A62E-8AA8111FEBD6Q38843414-DC0F4DEB-8D37-4E61-A0F6-DD81535AC721Q39348004-83854DD4-5895-4B66-B5A7-A1D831256974Q41472716-478DFA6A-612C-46E1-BAC7-F7807CC972A9Q42040480-ACADFAB7-F0C4-4A13-A863-6F6E4A5861BEQ42703677-821FCC6D-5F1F-4A92-84C6-1DCAC4007690Q42975877-0B1E9A55-433F-498D-AE4F-0F6D569743C2Q44649981-FDCAFBA0-AF06-4A01-BC2C-57E78B3534B5Q46715705-254AF5C9-C1DB-4177-B3B0-3DBB70E85865Q47381165-9DC5B43D-E2DC-447C-8300-6BFB88A811BDQ54260729-7E130AA0-79CC-428F-B877-3F06DA8CAE40
P2860
Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Toxicological evaluation of pr ...... uted corneal epithelium system
@ast
Toxicological evaluation of pr ...... uted corneal epithelium system
@en
Toxicological evaluation of pr ...... uted corneal epithelium system
@nl
type
label
Toxicological evaluation of pr ...... uted corneal epithelium system
@ast
Toxicological evaluation of pr ...... uted corneal epithelium system
@en
Toxicological evaluation of pr ...... uted corneal epithelium system
@nl
prefLabel
Toxicological evaluation of pr ...... uted corneal epithelium system
@ast
Toxicological evaluation of pr ...... uted corneal epithelium system
@en
Toxicological evaluation of pr ...... uted corneal epithelium system
@nl
P2860
P50
P356
P1476
Toxicological evaluation of pr ...... uted corneal epithelium system
@en
P2093
Aude Pauly
Luisa Riancho
P2860
P304
P356
10.1136/BJO.2010.189449
P407
P577
2011-03-22T00:00:00Z